Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 57 results found. Search for [ Pfizer-BioNTech COVID-19 vaccine side effects ]

Results 1 to 21 of 57
Reuters
April 10, 2021
A follow-up study of 33 people who received Moderna Inc's COVID-19 vaccine in early trials show the antibodies it induced are still present six months after the second dose


Reuters
April 2, 2021
The Medicines and Healthcare products Regulatory Agency said it had received no such reports of clotting events following use of the vaccine made by BioNTech SE and Pfizer Inc


BusinessToday.In
April 1, 2021
The vaccine was also effective in South Africa, where B.1.351 lineage of the virus is prevalent. It said nine cases of COVID-19 were observed in the country, all in the placebo group.


BusinessToday.In
March 31, 2021
The companies plan to submit the data from the trial to U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) to expand the use of the vaccine.


Associated Press
March 31, 2021
Health Minister Jens Spahn and state officials agreed unanimously to only give the vaccine to people aged 60 or older, unless they belong to a high-risk category for serious illness from COVID-19


Reuters
March 25, 2021
US health officials earlier in the week publicly rebuked the drugmaker for using \"outdated information\" when calculating that the vaccine was 79% effective


Reuters
February 19, 2021
Symptoms, as reported in clinical trials for the AstraZeneca shot, can include a high temperature or headache and are a normal sign that the body is generating an immune response


Reuters
February 4, 2021
The British researchers behind the trial said data on vaccinating people with the two different types of coronavirus vaccines could help understanding of whether shots can be rolled out with greater flexibility around the world


PB Jayakumar
January 26, 2021
Both COVID-19 vaccines being administered in India's extensive vaccination programme - Serum-Oxford-AstraZeneca's Covishield and Bharat Biotech's Covaxin - have a very short shelf life of just six months


PTI
January 22, 2021
There were no serious side effects in the participants enrolled for the phase 1 trial of Covaxin, according to the results published in The Lancet


BusinessToday.In
January 16, 2021
Norway COVID-19 immunisation: The Norwegian Institute of Public Health has cautioned against vaccinating elderly people above 80 years of age saying those with a short life span may not benefit much from the jab


BusinessToday.In
January 8, 2021
The UK government has already approved COVID-19 vaccine developed by the University of Oxford and AstraZeneca as well as Pfizer-BioNTech for emergency use in the country


Rashi Bisaria
New Delhi, January 7, 2021
US, UK warn Moderna, Pfizer vaccine may cause fever, weak immunity Debates continue in India whether the two COVID-19 vaccines that got emergency use authorisation from the country's drug regulator recently are safe and efficacious. The fact sheets for vaccine recipients in US and UK for Moderna and Pfizer-BioNTech vaccines say the vaccines are yet to be fully approved. Moderna's fact sheet for recipients says its vaccine is unapproved and 'may prevent COVID-19'. The UK government says it h...


Joe C Mathew
January 7, 2021
Fact sheets for recipients of Moderna and Pfizer-BioNTech vaccines in US and UK clarify that the vaccines are yet to be fully approved; recipients have been asked to get help if they experience severe side effects or allergic reactions


Manoj Sharma
January 5, 2021
There was immense pressure on governments to develop a vaccine at the earliest due to the destruction COVID-19 pandemic was unleashing. This led to a race among pharma companies to be the first to develop a vaccine


PTI
January 2, 2021
In the study, a team of experts led by allergists at Massachusetts General Hospital (MGH) in the US, proposed detailed advice so that individuals with different allergy histories can safely receive their COVID-19 vaccine


PTI
December 31, 2020
The researchers said this demonstrates 94.1 per cent efficacy in preventing symptomatic COVID-19, adding that cases of severe disease occurred only in participants who received the placebo


PTI
December 30, 2020
As per the report, Matthew's condition has improved since his symptoms peaked on Christmas Day but still feels fatigued


PTI
December 19, 2020
Serum Institute of India (SII) Chief Executive Officer Adar Poonawalla said the vaccine makers are going to propose this to the government while speaking at a virtual panel at the Carnegie India's Global Technology Summit on Friday


BusinessToday.In
December 19, 2020
Bolsonaro criticised pharmaceutical giant Pfizer. \"In the Pfizer contract it's very clear: 'we're not responsible for any side effects'. If you turn into a crocodile, it's your problem,\" said Bolsonaro


PAGES 1 OF 3  123